---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-073809"
form_type: "8-K"
ticker: "RYTM"
cik: "0001649904"
company_name: "RHYTHM PHARMACEUTICALS, INC."
filed_at: "2023-06-22T23:59:59+00:00"
generated_at: "2026-06-13T19:05:16.878903+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Rhythm Pharma annual meeting: all proposals approved by stockholders

## Summary
- 49,290,096 shares (~86.7%) present at June 21, 2023 meeting.
- Three Class III directors elected: Bedrosian, McGirr, Meeker with strong majorities.
- Ratification of Ernst & Young as auditor passed 49.2M for, 22k against.
- Advisory compensation vote approved 38.8M for, 1.9M against, 5.9M abstain.

## SEC filing metadata
- accession: 0001104659-23-073809
- form_type: 8-K
- ticker: RYTM
- cik: 0001649904
- company_name: RHYTHM PHARMACEUTICALS, INC.
- filed_at: 2023-06-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649904/000110465923073809/0001104659-23-073809-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649904/000110465923073809/tm2319441d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-073809
- JSON: https://secwatch.observer/filing/0001104659-23-073809.json
- Plain text: https://secwatch.observer/filing/0001104659-23-073809.txt

## Key facts
- Shareholder Votes
  RHYTHM PHARMACEUTICALS, INC. shareholders approved Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers at the 2023-06-21 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-21
  source text: Item 3 – Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649904/000110465923073809/0001104659-23-073809-index.htm
- Shareholder Votes
  RHYTHM PHARMACEUTICALS, INC. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm at the 2023-06-21 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-21
  source text: Item 2 - Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649904/000110465923073809/0001104659-23-073809-index.htm
- Shareholder Votes
  RHYTHM PHARMACEUTICALS, INC. shareholders approved Election of three Class III Directors to serve until the 2026 Annual Meeting of Stockholders at the 2023-06-21 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-21
  source text: Item 1 - Election of three Class III Directors to serve until the 2026 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649904/000110465923073809/0001104659-23-073809-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.